Literature DB >> 17035532

Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons.

Yanfang Rui1, Priyanka Tiwari, Zuoping Xie, James Q Zheng.   

Abstract

Defects in axonal transport are often associated with a wide variety of neurological diseases including Alzheimer's disease (AD). Beta-amyloid (Abeta) is a major component of neuritic plaques associated with pathological conditions of AD brains. Here, we report that a brief exposure of cultured hippocampal neurons to Abeta molecules resulted in rapid and severe impairment of mitochondrial transport without inducing apparent cell death and significant morphological changes. Such acute inhibition of mitochondrial transport was not associated with a disruption of mitochondria potential nor involved aberrant cytoskeletal changes. Abeta also did not elicit significant Ca2+ signaling to affect mitochondrial trafficking. However, stimulation of protein kinase A (PKA) by forskolin, cAMP analogs, or neuropeptides effectively alleviated the impairment. We also show that Abeta inhibited mitochondrial transport by acting through glycogen synthase kinase 3beta (GSK3beta). Given that mitochondria are crucial organelles for many cellular functions and survival, our findings thus identify an important acute action of Abeta molecules on nerve cells that could potentially contribute to various abnormalities of neuronal functions under AD conditions. Manipulation of GSK3beta and PKA activities may represent a key approach for preventing and alleviating Abeta cytotoxicity and AD pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035532      PMCID: PMC6674697          DOI: 10.1523/JNEUROSCI.3231-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Fast, convenient, and effective method to transiently transfect primary hippocampal neurons.

Authors:  M Köhrmann; W Haubensak; I Hemraj; C Kaether; V J Lessmann; M A Kiebler
Journal:  J Neurosci Res       Date:  1999-12-15       Impact factor: 4.164

2.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

Authors:  Gerardo Morfini; Györgyi Szebenyi; Ravindhra Elluru; Nancy Ratner; Scott T Brady
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

3.  Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity.

Authors:  R Bhatia; H Lin; R Lal
Journal:  FASEB J       Date:  2000-06       Impact factor: 5.191

4.  beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.

Authors:  C M Troy; S A Rabacchi; Z Xu; A C Maroney; T J Connors; M L Shelanski; L A Greene
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

5.  The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

Authors:  G Chen; L D Huang; Y M Jiang; H K Manji
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

6.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

7.  Synaptic and intrinsic mechanisms shape synchronous oscillations in hippocampal neurons in culture.

Authors:  A Bacci; C Verderio; E Pravettoni; M Matteoli
Journal:  Eur J Neurosci       Date:  1999-02       Impact factor: 3.386

Review 8.  The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

Authors:  C A Grimes; R S Jope
Journal:  Prog Neurobiol       Date:  2001-11       Impact factor: 11.685

Review 9.  Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

Authors:  Mark A Smith; Kelly L Drew; Akihiko Nunomura; Atsushi Takeda; Keisuke Hirai; Xiongwei Zhu; Craig S Atwood; Arun K Raina; Catherine A Rottkamp; Lawrence M Sayre; Robert P Friedland; George Perry
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

10.  Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Authors:  M P Coghlan; A A Culbert; D A Cross; S L Corcoran; J W Yates; N J Pearce; O L Rausch; G J Murphy; P S Carter; L Roxbee Cox; D Mills; M J Brown; D Haigh; R W Ward; D G Smith; K J Murray; A D Reith; J C Holder
Journal:  Chem Biol       Date:  2000-10
View more
  116 in total

Review 1.  Synaptic mitochondrial pathology in Alzheimer's disease.

Authors:  Heng Du; Lan Guo; Shirley ShiDu Yan
Journal:  Antioxid Redox Signal       Date:  2011-12-15       Impact factor: 8.401

2.  Early and selective impairments in axonal transport kinetics of synaptic cargoes induced by soluble amyloid β-protein oligomers.

Authors:  Yong Tang; David A Scott; Utpal Das; Steven D Edland; Kryslaine Radomski; Edward H Koo; Subhojit Roy
Journal:  Traffic       Date:  2012-02-27       Impact factor: 6.215

Review 3.  Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system.

Authors:  Nicholas M Kanaan; Gustavo F Pigino; Scott T Brady; Orly Lazarov; Lester I Binder; Gerardo A Morfini
Journal:  Exp Neurol       Date:  2012-06-19       Impact factor: 5.330

Review 4.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 5.  Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.

Authors:  Xiongwei Zhu; George Perry; Mark A Smith; Xinglong Wang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Imaging axonal transport of mitochondria.

Authors:  Xinnan Wang; Thomas L Schwarz
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

7.  Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.

Authors:  Xinglong Wang; Bo Su; Hyoung-gon Lee; Xinyi Li; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

8.  Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.

Authors:  Mathew A Sherman; Michael LaCroix; Fatou Amar; Megan E Larson; Colleen Forster; Adriano Aguzzi; David A Bennett; Martin Ramsden; Sylvain E Lesné
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

9.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

Authors:  Elizabeth M Rodrigues; April M Weissmiller; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

Review 10.  Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system.

Authors:  Jian-xin Shen; Jerrel L Yakel
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.